Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Midostaurin + Chemotherapy	250
Overall Study	STARTED	Placebo + Chemotherapy	251
Overall Study	Treated With Midostaurin/Placebo	Midostaurin + Chemotherapy	245
Overall Study	Treated With Midostaurin/Placebo	Placebo + Chemotherapy	249
Overall Study	Entered Induction Phase	Midostaurin + Chemotherapy	250
Overall Study	Entered Induction Phase	Placebo + Chemotherapy	251
Overall Study	Entered Consolidation Phase	Midostaurin + Chemotherapy	120
Overall Study	Entered Consolidation Phase	Placebo + Chemotherapy	129
Overall Study	Entered Post-Consolidation Phase	Midostaurin + Chemotherapy	45
Overall Study	Entered Post-Consolidation Phase	Placebo + Chemotherapy	27
Overall Study	COMPLETED	Midostaurin + Chemotherapy	2
Overall Study	COMPLETED	Placebo + Chemotherapy	1
Overall Study	NOT COMPLETED	Midostaurin + Chemotherapy	248
Overall Study	NOT COMPLETED	Placebo + Chemotherapy	250

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03512197/flow